Akeso's PD-1/CTLA-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations–Third Approved Indication for Cadonilimab HONG KONG, June 5, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) ("Akeso" or the… CISION PRNewswireJune 5, 2025
Press Release Tiger Brokers Hong Kong Launches Inaugural Art Prize with HKBU AVA to Inspire Young Artists and Creative Crossovers HONG KONG, June 5, 2025 /PRNewswire/ — Tiger Brokers (HK) Global Limited… CISION PRNewswireJune 5, 2025
JW Therapeutics Announces Approval of Relmacabtagene Autoleucel Injection (Carteyva®) for Marketing in Macao SHANGHAI, June 4, 2025 /PRNewswire/ — JW Therapeutics (HKEx: 2126), an independent… CISION PRNewswireJune 5, 2025
Press Release NEXCOM Highlights Dual 5G Security Solutions and ODM Expertise at Interop Tokyo 2025 Booth 7J10 | June 11–13 | Makuhari Messe TAIPEI, June 5, 2025… CISION PRNewswireJune 5, 2025
Press Release Lockheed Martin Aims to Cultivate Filipino Talent, Stimulate Job Growth and Advance Local Defense Sector with Industrial Collaboration Proposal MANILA, Philippines, June 5, 2025 /PRNewswire/ — Lockheed Martin has outlined robust… CISION PRNewswireJune 5, 2025
Synpulse successfully partners with Judo Bank to complete its Core Banking Transformation SINGAPORE, June 5, 2025 /PRNewswire/ — Synpulse, a global management consultancy with… CISION PRNewswireJune 5, 2025
Press Release Made to Create, Built to Grow — Wacom Introduces the New Wacom Cintiq Line Wacom unveils a new generation of Wacom Cintiq pen displays — the… CISION PRNewswireJune 5, 2025
Innovent's IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Receives Second NMPA Breakthrough Therapy Designation for Immuno-resistant Squamous Non-Small Cell Lung Cancer SAN FRANCISCO and SUZHOU, China, June 5, 2025 /PRNewswire/ — Innovent Biologics,… CISION PRNewswireJune 5, 2025
